Literature DB >> 11672830

Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis.

L Benvegnù1, A Alberti.   

Abstract

To compare incidence, risk factors and morphologic pattern of hepatocellular carcinoma (HCC) development in hepatitis B virus (HBV) and hepatitis C virus (HCV) related cirrhosis, 401 patients were followed prospectively by periodic ultrasound examination for 14-189 months (mean: 84.8+/-36.7). During follow-up, 77 (19.2%) patients developed HCC, with 5 and 10 year cumulative incidence of 10 and 27.5%, respectively. The risk of HCC was significantly higher in HBV and HCV co-infected patients (P=0.014) compared to those with single HBsAg or anti-HCV (antibodies to hepatitis C virus) positivity. In anti-HCV positive cases the annual risk of HCC increased from 2% in the first 5 year period to 4% in the third 5 year period, while it decreased from 2 to 0% in the same time periods in the HBsAg positive group. By Cox's regression, age above 59 years (P=0.001), male sex (P=0.09), longer duration (P=0.04) and more advanced stage (P=0.01) of cirrhosis, lower platelets count (P=0.001) and higher ALT levels were significant risk factors for HCC in anti-HCV positive patients, while only high alpha-fetoprotein (AFP) levels during follow-up (P=0.04) was a significant risk factor for HCC in HBsAg positive cases. The pattern of HCC was nodular in 63 (81.8%) patients and infiltrating in 14 (18.2%), and the former type was associated with older age (P=0.0001), longer duration (P=0.002) and more advanced stage (P=0.0001) of cirrhosis but not with the viral etiology of disease. In contrast, development of infiltrating HCC was unrelated to age and disease duration and stage, and was associated with male sex (P=0.01), HBV infection (P=0.06) and HBV and HCV co-infection (P=0.0001). Our results indicate different incidence profile, risk factors and patterns of morphogenesis of HCC development in HBV and HCV associated cirrhosis, suggesting different mechanisms of carcinogenesis.

Entities:  

Mesh:

Year:  2001        PMID: 11672830     DOI: 10.1016/s0166-3542(01)00185-1

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  7 in total

1.  Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in Korea.

Authors:  Yon Mi Sung; Dongil Choi; Hyo K Lim; Won Jae Lee; Seung Hoon Kim; Min Ju Kim; Seung Woon Paik; Byung Chul Yoo; Kwang Cheol Koh; Joon Hyoek Lee; Moon Seok Choi
Journal:  Korean J Radiol       Date:  2006 Jul-Sep       Impact factor: 3.500

2.  Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma.

Authors:  L Messerini; L Novelli; C E Comin
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

3.  Microarray-based gene expression analysis of hepatocellular carcinoma.

Authors:  Thorsten Maass; Ioannis Sfakianakis; Frank Staib; Markus Krupp; Peter R Galle; Andreas Teufel
Journal:  Curr Genomics       Date:  2010-06       Impact factor: 2.236

4.  Predictors of seropositivity for human herpesvirus type 8 in patients with mild cirrhosis.

Authors:  Kuo-Chih Tseng; Ming-Nan Lin; Tang-Yuan Chu; Jen-Pi Tsai; Cheng-Chuan Su
Journal:  Emerg Microbes Infect       Date:  2017-06-07       Impact factor: 7.163

5.  Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma.

Authors:  Amna Subhan Butt; Saeed Hamid; Ashfaq Ahmad Wadalawala; Mariam Ghufran; Ammar Asrar Javed; Omer Farooq; Bilal Ahmed; Tanveer Ul Haq; Wasim Jafri
Journal:  BMC Res Notes       Date:  2013-04-08

6.  Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.

Authors:  Maria Makarova; Alexandra Krettek; Mikhail Y Valkov; Andrej M Grjibovski
Journal:  Int J Circumpolar Health       Date:  2013-05-13       Impact factor: 1.228

7.  Chronic viral hepatitis and hepatocellular carcinoma.

Authors:  Yagil Barazani; Jonathan R Hiatt; Myron J Tong; Ronald W Busuttil
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.